Tumorassociated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer

Tumor-associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer

18:00 EDT 28 Mar 2019 | Pharmaceutical Processing

News
A frontline chemotherapy drug is made less effective because similar compounds released by tumor-associated immune cells block the drug's action.
Contributed Author: 
Michigan Medicine - University of Michigan
Topics: 
Oncology

More From BioPortfolio on "Tumor-associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer"